Is Brightcom a Debt-Free Company? A Closer Look at Their Financial Health

Brightcom group shares have been in a trading suspension for over 9 months now, and there is no clarity on the revocation of the suspension. On April 2, 2025, Brightcom Group released a weekly update wherein it stated that it is difficult to provide an exact timeline for the revocation of trading suspension as the matter is currently before the Court.

The company is diligently exploring all options to obtain the Court’s approval for an early revocation—possibly within days. While remaining optimistic for a quick resolution, we are also ready to handle any unforeseen developments in case of delays.

Is Brightcom a Debt-Free Company?

In Q2 FY24, consolidated revenue reached ₹1,814 crores, compared to ₹1,683 crores in the same quarter of the previous year, reflecting a growth of 7.8%. Consolidated PAT stood at ₹352 crores, up from ₹321 crores in Q2 of the previous year, representing a growth of 9.7%. As of September 2024, the company reported a reserve of ₹7,763 crore and nil borrowing, making it a zero-debt company.

The current product offerings include ad campaigns across Video, Banners, Email, Search, Social, and Mobile marketing. The process focuses on monetizing ad traffic by targeting very specific demographics with high buying power, making this the most profitable vertical. We are exploring options to strengthen operations in the APAC and EMEA markets.

Brightcom Group Outlook

  • DOOH / Audio OTT / Data Monetisation: The focus is on Digital Out-Of-Home (DOOH), Audio, OTT, and Podcast platforms, alongside sensor and data monetization. Additionally, there is an emphasis on the physical web from a monetization standpoint.
  • AI / ML and Quantum Computing: Brightcom Group aims to build analytical and predictive models using AI, Machine Learning (ML), and Quantum Computing, offering higher speeds and solving complex problems.

 

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Best Gold ETFs in India for April 2025 – Based on 5Y CAGR

Investing in gold has always been a hedge for investors as it has been considered a safer bet traditionally due to its increasing prices over the years. In the realm of gold investing, there are many ways to invest in gold, such as gold bonds, gold mutual funds, gold ETFs, physical gold and more. In this read, we will explore the Best Gold ETFs in India for April 2025 based on 5Y CAGR.

A Gold ETF is an exchange-traded fund that seeks to mirror the price of domestic physical gold. These are passive investment vehicles tied to gold prices and typically invest in gold bullion. Listed and traded on the National Stock Exchange of India (NSE) and the Bombay Stock Exchange Ltd. (BSE), Gold ETFs function similarly to company stocks. They are traded on the cash segment of both BSE and NSE, allowing for continuous buying and selling at market prices.

Best Gold ETFs in India for April 2025

Name Market Cap (₹ Crore) 5Y CAGR (%)
HDFC Gold Exchange Traded Fund 1,906.09 14.83
ICICI Prudential Gold ETF 1,905.05 14.80
Nippon India ETF Gold BeES 5,168.88 14.79
SBI Gold ETF 2,644.09 14.05
Kotak Gold ETF 1,984.14 13.68

Note: The Gold ETFs mentioned above have been selected and sorted based on 5Y CAGR as of April 3, 2025

Overview of the Best Gold ETFs in India

1. HDFC Gold Exchange Traded Fund

The HDFC Gold ETF is an exchange-traded fund designed to mirror the performance of gold. It offers investors a simple and affordable way to invest in gold through digital means.

Key Metrics

  • Alpha: 9.87
  • NAV: ₹78.22

2. ICICI Prudential Gold ETF

ICICI Prudential Gold ETF aims to provide investment returns that track the performance of domestic prices of Gold derived from the LBMA AM fixing prices.

Key Metrics

  • Alpha: 10.04
  • NAV: ₹78.03

3. Nippon India ETF Gold BeES

Nippon India ETF Gold BeES is an ended scheme, listed on the Exchange in the form of an Exchange Traded Fund (ETF) investing in physical gold.

Key Metrics

  • Alpha: 9.52
  • NAV: ₹76.05

4. SBI Gold ETF

SBI Gold ETF invests in gold and gold-related instruments, and the objective of the scheme is to track the price of gold.

Key Metrics

  • Alpha: 9.91
  • NAV: ₹78.15

5. Kotak Gold ETF

Kotak Gold ETF is an open-ended gold exchange-traded fund which invests in physical gold and endeavors to track the domestic spot price of gold as closely as possible.

Key Metrics

  • Alpha: 10.41
  • NAV: ₹76.39

Benefits of Investing in Gold ETFs

  • Diversification: Gold has historically been a haven asset. It often performs well during times of market volatility or inflation. Investing in Gold ETFs can help diversify your portfolio, balancing risk and potentially boosting long-term returns.
  • Liquidity: Gold ETFs are traded on stock exchanges just like regular stocks, making them highly liquid. You can buy or sell your investment during market hours, which offers flexibility and convenience.
  • No Physical Storage Hassles: When you buy physical gold, you need a safe and secure place to store it, which can be costly. Gold ETFs eliminate the need for physical storage, as the gold is held by the ETF issuer in a secure vault.
  • Lower Costs: Gold ETFs typically have lower transaction costs compared to buying and selling physical gold, as there are no premiums or VAT (in most jurisdictions) associated with purchasing physical gold.

Factors to Consider Before Investing in Gold ETFs:

  • Expense Ratio: Gold ETFs usually charge an annual management fee, which is the “expense ratio.” While these fees are generally low compared to other types of funds, it’s still essential to compare the expense ratios of different Gold ETFs.
  • Underlying Assets: Some Gold ETFs are backed by physical gold stored in vaults, while others may be backed by gold futures contracts. The type of asset backing the ETF can affect its risk and performance. Make sure you understand how the ETF is structured.
  • Market Risk: Like any other asset class, the value of gold ETFs is subject to market risks. Gold prices can be volatile due to factors like changes in interest rates, geopolitical instability, or currency fluctuations. Gold ETFs are not immune to these risks.

Conclusion

Gold ETFs can be a convenient and cost-effective way to gain exposure to gold. However, like any investment, it’s important to understand the potential risks, such as market volatility, liquidity, and tracking errors.

Want to plan regular withdrawals? Our SWP Calculator helps you calculate how much you can withdraw while keeping your investments intact. Try it now!

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Mutual Fund investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Central Bank of India Shares Fell After Bank Reported Q4FY25 Performance

On April 3, 2025, Central Bank of India shares were in focus, reaching a day low of ₹35.95 at 11:50 AM after opening at ₹37.19. The fall in Central Bank of India shares came after the bank released its update for Q4FY25.

CASA Expected to Drop in Q4FY25

As of March 31, 2024, the total business amounted to ₹6,36,756 million, which is projected to increase to ₹7,05,196 million by March 31, 2025, reflecting a YoY growth of 10.75%. Total deposits are expected to rise from ₹3,85,011 million to ₹4,12,665 million, showing a growth of 7.18%. The CASA (Current Account Savings Account) percentage, excluding inter-bank deposits, is expected to decrease slightly from 50.02% to 48.91%.

On the other hand, gross advances are likely to grow by 16.20%, increasing from ₹2,51,745 million to ₹2,92,531 million. As a result, the CD (Credit-Deposit) ratio, excluding inter-bank advances, is anticipated to improve by 554 basis points, from 65.59% to 71.13%. As of March 31, 2025, the Central Bank of India has achieved a significant milestone by crossing a ₹7.00 Lakh crore business.

Central Bank of India QIP

On March 28, 2025, the bank announced that its Board had approved the issue and allotment of 37,04,61,842 Equity Shares to eligible QIBs at the issue price of ₹40.49 per Equity Share, which includes a discount of ₹ 2.13, i.e., 4.99% of the floor price. As a result, the Central Bank of India raised ₹1,500 crore from the QIP.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

SEBI Allowed IAs and RAs to Charge Advance Fees For Up to One Year

On Wednesday, April 3, 2025, the capital market regulator, the Securities and Exchange Board of India (SEBI), announced new guidelines allowing investment advisers (IAs) and research analysts (RAs) to charge advance fees for up to 1 year. This is an update from the previous rules, where IAs could charge fees in advance for up to two quarters, and RAs could only charge for a quarter.

SEBI stated in circular, “If agreed by the client, IAs and RAs may charge fees in advance, however, such advance shall not exceed fees for a period of one year”

Scope of New Provision for RAs and IAs

The new provisions regarding fee limits, payment methods, fee refunds, advance fees, and breakage fees will apply only to individual clients and Hindu Undivided Families (HUFs), provided these clients are not accredited investors. These provisions will not apply to non-individual clients, accredited investors, or institutional investors seeking advice from a proxy adviser. For these clients, fee terms will be governed by bilaterally negotiated contracts.

Why SEBI Allowed Changes?

The changes came after concerns were raised regarding the restrictions on advance fee collection. SEBI received representations from both IAs and RAs, who argued that the existing limits on advance fees discouraged long-term recommendations. In response, SEBI issued a consultation paper to extend the advance fee period to one year for both IAs and RAs, which has now been implemented.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Dabur Share Price Drops ~7% After Reporting Weak Performance in Q4FY25

On April 3, 2025, Dabur share price fell ~7%, reaching a day low of ₹458.25 at 10:25 AM after opening at ₹479.95 on BSE. The fall in Dabur share price after the company released subdued performance in Q4FY25.

Subdued Performance in Q4FY25

Due to delayed and shortened winters, a slowdown in urban markets, and weakness in general trade, India’s FMCG sector is expected to experience a decline in the mid-single digits. As a result, Dabur’s consolidated revenue is projected to remain flat in Q4 FY25. Additionally, Dabur anticipates a year-on-year contraction of 150-175 basis points in Q4 EBITDA margins, driven by inflationary pressures and operating deleverage.

In Q4, Dabur’s rural business showed resilience, outpacing the growth of urban markets. In terms of channels, organised trade—including modern trade, e-commerce, and quick commerce—sustained its growth momentum, while general trade remained under pressure. Key international markets, such as the MENA region, Egypt, and Bangladesh, are expected to deliver strong performance, resulting in robust double-digit growth in constant currency terms for the international business.

“We remain committed to driving profitable growth despite the current headwinds in demand. Our internal efforts, such as investing in brand building, enhancing go-to-market strategies, and increasing operational efficiency, will enable us to achieve this objective. Furthermore, we anticipate that the incentives outlined in the recent Union Budget will stimulate consumption and facilitate a recovery in the FMCG sector, which Dabur is well placed to capitalise on,” Dabur said in a statement.

Conclusion

After reporting subdued performance in Q4FY25, Dabur share price reacted negatively. The Q4FY25 performance was disrupted due to delayed and shortened winters, a slowdown in urban markets, and weakness in general trade.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

MOIL Share Price Rose After Reporting Best Ever Production in FY25

On April 3, 2025, MOIL share price was in focus, reaching a day high of 337.55 after opening at 334.60. The gain in MOIL share price follows the release of the best-ever financial year performance in FY’25

Strong Production Across Various Sectors

MOIL has achieved significant milestones in its key performance indicators, demonstrating strong growth across various sectors. The company reached a record production of 18.02 lakh tonnes of manganese ore, marking a 2.7% increase compared to the previous year. Additionally, manganese ore sales also hit a record high of 15.87 lakh tonnes, reflecting a 3.3% year-on-year growth.

Ferro manganese production surged to 12,000 MT, an 18% improvement over the previous year. Moreover, exploratory core drilling reached 1,07,530 meters, showing a 22% increase from the same period last year. This extensive exploration will play a crucial role in expanding production from current mines and developing new manganese mines across the country.

MOIL 9MFY25 Earnings Highlights

During 9MFY25, MOIL reported a remarkable 32% increase in Profit After Tax (PAT), reaching ₹361.55 crore compared to the same period last year. Revenue from operations stood at ₹1,151.55 crore, reflecting an 11% growth over the corresponding period in the previous year. MOIL achieved a production of 13.30 lakh MT of manganese ore, marking a 5% year-on-year increase. Manganese ore sales were recorded at 11.39 lakh MT, which saw a 4% growth year-on-year.

In its continued focus on exploration, MOIL completed 72,350 meters of exploratory core drilling during the period of April- December 2024, a 19% increase compared to the previous year. Additionally, the Board approved an interim dividend of ₹4.02 per share for FY 2025, which is approximately 15% higher than last year’s interim dividend of ₹3.50 per share.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Pharma Stocks Rose After Trump Exempted Sector from Reciprocal Tariffs

The US President, Donald Trump, announced reciprocal tariffs on over 180 countries, including India, on April 2, 2025. Trump imposed 26% reciprocal tariffs, half the rate India charges on US imports. Donald Trump has exempted pharmaceutical imports from the reciprocal tariff. As a result, the Nifty Pharma Index rose 4.31% to 21,854.90 at 09:40 AM. All 20 stocks on the Nifty Pharma index were in green, where Gland Pharma, Lupin, Aurobindo Pharmaceuticals, Sun Pharma and Natco Pharma were the top gainers

Pharma Stocks in Focus

Company Name US Revenue (%) in FY24
Gland Pharma 54
Aurobindo Pharma 48
Lupin 37
Dr Reddy’s Laboratories 48
Zydus Lifesciences 46

On April 3, 2025, Gland pharma share price rose ~9%, reaching a day high of 1,767.70. Other pharma stocks, such as Aurobindo Pharma, Lupin, Dr Reddy’s, and Zydus Lifesciences, rose over 5% at 09:45 AM.

Pharma Sector in India

As of November 2024, the Indian pharmaceutical industry ranked the 3rd largest in the world by production volume. Over the years, it has developed into a robust sector, growing at a compound annual growth rate (CAGR) of 9.43% over the past 9 years. India meets over 50% of the global demand for vaccines, 40% of the USA’s demand for generics, and 25% of the UK’s total medicine needs. The domestic industry consists of around 3,000 drug companies and approximately 10,500 manufacturing facilities, cementing India’s significant role in the global pharmaceuticals market.

The pharmaceutical sector is one of the top ten most attractive industries for foreign investment in India. Indian pharmaceutical exports reach over 200 countries worldwide, including highly regulated markets such as the USA, Western Europe, Japan, and Australia. India also supplied approximately 45 tonnes and 400 million tablets of hydroxychloroquine to around 114 countries globally.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

United Spirits Shares to Trade Ex-Date on April 3: Interim Dividend of ₹4

United Spirits share price will trade ex-date on April 3, 2025, meaning that the shareholders registered in the company’s books will be eligible for the ₹4 interim dividend.

United Spirits Dividend History

Ex-Date Dividend Type Dividend Amount (₹)
July 12, 2024 Final 5.00
Nov 17, 2023 Interim 4.00

United Spirits Q3FY25 Earnings Highlights

In Q3FY25, the company reported consolidated net sales of ₹3,433 Cr, reflecting a year-on-year growth of 14.4%, which is broadly in line with the growth in its standalone business. Consolidated EBITDA stood at ₹568 Cr, marking a growth of 16.9% compared to the previous year. The company’s consolidated profit after tax for the quarter was ₹335 Cr.

Ms. Hina Nagarajan, CEO & Managing Director, commenting on the Q3FY25 performance, said: “Amidst a moderate but sequentially improving demand environment, we have delivered a quarter in line with our aspirations buoyed by the festive season and fast scale-up in the state of Andhra Pradesh. Looking ahead, we remain cautiously optimistic in the short-term while remaining committed to the long-term potential of the India consumer story.”

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

How Trump’s 26% Reciprocal Tariffs Could Impact the Indian Stock Market?

On April 2, 2025, US President Donald Trump made an announcement related to the reciprocal tariffs on trading partners. Donald Trump made no exclusion for any country as he announced reciprocal tariffs on more than 180 countries. In addition, Trump also announced the imposition of a 10% baseline tariff apart from country-specific tariffs.

Trump declared a 26% reciprocal tariff on India, which is half the rate India charges on U.S. imports. Additionally, he introduced a 25% tariff on automobile imports, a move that could affect auto stocks like Tata Motors and Samvardhana Motherson.

Impact of Trump’s Tariff on the Indian Stock Market

Trump’s tariffs could push a negative reaction in the Indian stock market, as indicated by the drop of ~0.21% in Gift Nifty at 08:15 AM on April 2, 2025.

Sectors such as IT and automobiles could experience selling pressure, but in the medium to long term, the market is expected to adjust to the impact. However, as per experts, Trump’s tariff may not have a major negative effect on the economy, which provides some reassurance for the domestic market..

Major Sectoral Impact

Electronic Sector

The reciprocal tariffs will impact the electronics sector, which relied on the U.S. for 32% of its exports during the fiscal year ending March 2024.

However, for Apple, which shifted part of its assembly operations to India, there remains a strong incentive to continue exporting phones from India to the U.S., given the 34% reciprocal tariff added to the existing 20% duty on imports from China.

Textile Sector

In FY24, India exported $9.6 billion worth of textiles and apparel to the U.S., representing about 28% of the total exports in this category. The new round of tariffs could make Indian exports more competitive compared to China and Vietnam, which held market shares of 21% and 19%, respectively, compared to India’s 6%. The reciprocal tariffs have raised duties by 34% for China and 46% for Vietnam.

Key textile stocks to monitor on April 3 include Welspun, Trident, Arvind Limited, KPR Mill, Vardhaman, and Page Industries.

Auto Sector

Truck exporters are likely to face challenges from the increased tariffs in the U.S. For example, Bharat Forge derives about 20% of its revenue from the U.S., while auto component makers such as Samvardhana Motherson (18.6% of revenue from U.S. exports) and Suprajit Engineering (21.78%) are also expected to be impacted.

Pharma Sector Exempted from Tariffs

US President Donald Trump has exempted pharmaceutical exports from the reciprocal tariff. This would come as a relief for companies like Sun Pharma (33% of revenue from the US), Dr Reddy’s Laboratories (48.5%), and Aurobindo Pharma(48.3%).

Certain items such as steel, copper, bullion, energy, and other minerals not available in the U.S. are exempt from the latest tariff announcements. The sharp 4% drop in global copper prices, triggered by the Trump tariffs, is expected to benefit Indian wire and cable manufacturers as well as aluminum producers like Hindalco and Vedanta.

Conclusion

Following the announcement of a 26% reciprocal tariff on imports from India by US President Donald Trump, the Indian stock market may see a negative reaction from investors. This announcement could impact major sectors like automotive, electronics, textile and others.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Stocks That Hit Circuit Limits On April 2, 2025: Godfrey Phillips, NACL and More

On April 2, 2025, BSE Sensex closed 0.78% higher at 76,617.44, while Nifty50 settled higher at 23,332.35, up 0.72%. Amidst the market downturn, stocks like PSB, Blue Jet, and Godfrey Phillips hit circuit limits, reflecting significant price movements. Check out the full list of stocks hitting circuits today.

Stocks That Hit Lower Circuit on April 2, 2025

Symbol LTP %chng Price Band % Volume(Lakhs) Value(₹ Crores)
GODFRYPHLP 7,149.95 0.6 5 1.38 96.55
WEBELSOLAR 1,191.10 -5 5 5.59 68.13
SHAILY 1,689.90 -5 5 1.51 25.6
PANACEABIO 443.35 -1.95 5 2.19 9.75
BLUEJET 798.6 -5 5 0.41 3.29

Stocks That Hit Upper Circuit on April 2, 2025

Symbol LTP %chng Price Band % Volume(Lakhs) Value(₹ Crores)
HESTERBIO 1,786.70 20 20 7.23 122.21
STYLEBAAZA 312.12 20 20 33.93 100.26
NACLIND 123.14 10 10 44.87 54.65
V2RETAIL 1,809.90 5 5 2.92 52.54
AVALON 800 3.91 5 6.18 49

Overview of Companies Hitting Circuits Today

  • Godfrey Phillips 

Godfrey Phillips saw a marginal dip of 0.6%, hitting a 5% lower circuit, with a trading volume of 1.38 lakhs and a value of ₹96.55 crores.

  • Blue Jet

Blue Jet stock fell by 5%, hitting the lower circuit with a volume of 0.41 lakhs and a value of ₹3.29 crores.

  • Hester Biosciences 

Hester Biosciences surged by 20%, hitting the upper circuit with a volume of 7.23 lakhs and a value of ₹122.21 crores.

  • NACL

NACL Industries saw a 10% increase, hitting the upper circuit with a volume of 44.87 lakhs and a value of ₹54.65 crores.

  • V2 Retail

V2 Retail rose by 5%, hitting the upper circuit with a volume of 2.92 lakhs and a value of ₹52.54 crores..

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks; read all the related documents carefully before investing.